|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for GCLM |
Basic gene info. | Gene symbol | GCLM |
Gene name | glutamate-cysteine ligase, modifier subunit | |
Synonyms | GLCLR | |
Cytomap | UCSC genome browser: 1p22.1 | |
Genomic location | chr1 :94352589-94375012 | |
Type of gene | protein-coding | |
RefGenes | NM_002061.2, | |
Ensembl id | ENSG00000023909 | |
Description | GCS light chainGSC light chaingamma-ECS regulatory subunitgamma-glutamylcysteine synthetase regulatory subunitglutamate--cysteine ligase modifier subunitglutamate--cysteine ligase regulatory subunitglutamate-cysteine ligase (gamma-glutamylcysteine s | |
Modification date | 20141207 | |
dbXrefs | MIM : 601176 | |
HGNC : HGNC | ||
Ensembl : ENSG00000023909 | ||
HPRD : 03106 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GCLM | |
BioGPS: 2730 | ||
Gene Expression Atlas: ENSG00000023909 | ||
The Human Protein Atlas: ENSG00000023909 | ||
Pathway | NCI Pathway Interaction Database: GCLM | |
KEGG: GCLM | ||
REACTOME: GCLM | ||
ConsensusPathDB | ||
Pathway Commons: GCLM | ||
Metabolism | MetaCyc: GCLM | |
HUMANCyc: GCLM | ||
Regulation | Ensembl's Regulation: ENSG00000023909 | |
miRBase: chr1 :94,352,589-94,375,012 | ||
TargetScan: NM_002061 | ||
cisRED: ENSG00000023909 | ||
Context | iHOP: GCLM | |
cancer metabolism search in PubMed: GCLM | ||
UCL Cancer Institute: GCLM | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for GCLM(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: GCLM |
Familial Cancer Database: GCLM |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
KEGG_GLUTATHIONE_METABOLISM REACTOME_SULFUR_AMINO_ACID_METABOLISM REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES |
![]() | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: GCLM |
MedGen: GCLM (Human Medical Genetics with Condition) | |
ClinVar: GCLM | |
Phenotype | MGI: GCLM (International Mouse Phenotyping Consortium) |
PhenomicDB: GCLM |
Mutations for GCLM |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
There's no structural variation information in COSMIC data for this gene. |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows GCLM related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
AA451832 | SNTG2 | 3 | 72 | 2 | 1063989 | 1064058 | GCLM | 71 | 451 | 1 | 94353207 | 94353587 | |
AI133413 | SAMD9 | 8 | 665 | 7 | 92729970 | 92730629 | GCLM | 656 | 751 | 1 | 94354014 | 94354110 |
![]() |
Top |
![]() |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 1 | |||
GAIN (# sample) | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 1 | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=17) | (# total SNVs=4) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr1:94354650-94354650 | p.E241* | 2 |
chr1:94362293-94362293 | p.E141K | 2 |
chr1:94354618-94354618 | p.S251S | 1 |
chr1:94362183-94362183 | p.Q177H | 1 |
chr1:94367183-94367183 | p.E79Q | 1 |
chr1:94354623-94354623 | p.Y250D | 1 |
chr1:94362191-94362191 | p.L175M | 1 |
chr1:94370097-94370097 | p.I58I | 1 |
chr1:94354629-94354629 | p.L248M | 1 |
chr1:94362251-94362251 | p.Q155* | 1 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 2 | 1 |   | 1 |   |   | 1 |   | 1 |   | 1 | 1 | 2 | 1 |   |   | 1 | 2 |   | 4 |
# mutation | 2 | 1 |   | 1 |   |   | 1 |   | 1 |   | 1 | 1 | 2 | 1 |   |   | 1 | 2 |   | 4 |
nonsynonymous SNV | 1 | 1 |   | 1 |   |   | 1 |   |   |   | 1 | 1 | 1 | 1 |   |   | 1 | 2 |   | 2 |
synonymous SNV | 1 |   |   |   |   |   |   |   | 1 |   |   |   | 1 |   |   |   |   |   |   | 2 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr1:94354623 | p.L200L | 1 |
chr1:94367168 | p.M196I | 1 |
chr1:94360188 | p.L190F | 1 |
chr1:94370097 | p.L175M | 1 |
chr1:94360225 | p.W147L | 1 |
chr1:94370100 | p.E141G | 1 |
chr1:94360237 | p.N137I | 1 |
chr1:94360257 | p.A128V | 1 |
chr1:94362191 | p.V116I | 1 |
chr1:94362274 | p.D84Y | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for GCLM |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |||||
DCUN1D1,DNTTIP2,DOCK7,DR1,GCLM,HIAT1,HS2ST1, LRRC40,LRRC58,LUZP6,MOB1A,NCKAP1,PKN2,ROCK2, RRAGC,RTCA,SASS6,TAF13,TMED5,TXNRD1,ZNF644 | APC,CLINT1,DCUN1D1,DNM1L,EFR3A,FBXW11,GCLM, HIPK1,INTS2,KIF5B,MAPK1,NCKAP1,PPP2R5E,RNF141, RPRD1A,SCYL2,TNPO1,UEVLD,WDR44,ZBTB38,ZFP91 | ||||
![]() | |||||
ABCD3,AGL,AHCYL1,MAB21L3,CLCC1,DBT,DNTTIP2, FNBP1L,GCLM,GPSM2,HOOK1,LRRC8D,NRAS,SIKE1, TMED5,TMEM56,TRIM33,VANGL1,WDR3,ZNF644,ZNHIT6 | AGMAT,AIMP2,AK2,ALDH3A2,B4GALNT2,C2orf47,C2orf69, GLIS3-AS1,ETFA,ETNK1,FDX1,GCLM,HMGB3,LHFPL3, ME2,MGST1,MTCH2,OXNAD1,PITX2,TMED5,UGDH |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for GCLM |
![]() |
DB Category | DB Name | DB's ID and Url link |
![]() |
* Gene Centered Interaction Network. |
![]() |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00142 | glutamate-cysteine ligase, modifier subunit | approved; nutraceutical | L-Glutamic Acid | ![]() | ![]() |
DB00151 | glutamate-cysteine ligase, modifier subunit | approved; nutraceutical | L-Cysteine | ![]() | ![]() |
DB00515 | glutamate-cysteine ligase, modifier subunit | approved | Cisplatin | ![]() | ![]() |
DB00143 | glutamate-cysteine ligase, modifier subunit | approved; nutraceutical | Glutathione | ![]() | ![]() |
Top |
Cross referenced IDs for GCLM |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |